Výsledky vyhledávání

Akademický článek

Autor: Mitchell Lycett, Karl Ng

Publikováno v: Advances in Clinical Neuroscience & Rehabilitation, Vol , Iss (2024)

Muscle excitability is an experimental technique that probes the properties of the muscle fibre membrane in vivo. In doing so one can make determinations about the excitability of the membrane during different phases of the muscle velocity recovery c

Externí odkaz: https://doaj.org/article/53f3cd51ef5e420fb25353711030aeac

Zobrazit plný text záznamu

Akademický článek

Hypertrophic olivary degeneration associated with bilateral vocal cord adductor dystonia

Autor: Mitchell Lycett, Cathy Kexin Cui, Dijana Dragicevich, Roger Harris, Karl Ng

Publikováno v: BMC Neurology, Vol 23, Iss 1, Pp 1-4 (2023)

Abstract Background Hypertrophic olivary degeneration (HOD) is a rare condition caused by lesions within the dentato-rubro-olivary pathway, resulting in ocular nystagmus and palatal myoclonus (oculopalatal tremor) but not usually dystonia. Dystonia i

Externí odkaz: https://doaj.org/article/d1672e71afc44b28be8f69498a8dd761

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Increase in ACC GABA+ levels correlate with decrease in migraine frequency, intensity and disability over time

Autor: Aimie L. Peek, Andrew M. Leaver, Sheryl Foster, Nicolaas A. Puts, Georg Oeltzschner, Luke Henderson, Graham Galloway, Karl Ng, Kathryn Refshauge, Trudy Rebbeck

Publikováno v: The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-13 (2021)

Abstract Background An imbalance between inhibitory and excitatory neurometabolites has been implicated in chronic pain. Prior work identified elevated levels of Gamma-aminobutyric acid + macromolecules (“GABA+”) using magnetic resonance spectros

Externí odkaz: https://doaj.org/article/9267bf675c3d490fb6162cdb25239daa

Zobrazit plný text záznamu

Akademický článek

Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report

Autor: Sophie Chatterton, John Douglas Edward Parratt, Karl Ng

Publikováno v: Frontiers in Neurology, Vol 13 (2022)

IntroductionEculizumab has been shown to be an effective and typically well-tolerated medication in the treatment of neuromyelitis optica spectrum disorder (NMOSD) in maintaining disease remission in patients who are aquaporin-4 water channel autoant

Externí odkaz: https://doaj.org/article/e5dd12283f194cf6838ef10fbc1be0ac

Zobrazit plný text záznamu